RecruitingNot ApplicableNCT06114615

Digital Monitoring for Patients Post Coronary Interventions to Reduce Risk for Recurrent Adverse Cardiovascular Events


Sponsor

University of California, Davis

Enrollment

200 participants

Start Date

Jan 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The study aims to support patients immediately after percutaneous coronary intervention (PCI) by implementing a telemonitoring program. Eligible patients have coronary heart disease and undergo PCI. The intervention group receives remote monitoring and text-based follow-up, with established health goals and education on using the telemonitoring application, along with necessary devices. The control group gets standard care. Outcomes measured include blood pressure, LDL levels, patient satisfaction, revascularization, and mortality. The study findings will enhance patient care after PCI and contribute evidence for widespread telemonitoring implementation in healthcare systems, aiding medical therapy and lifestyle modifications.


Eligibility

Inclusion Criteria1

  • Includes patients with coronary heart disease diagnosis and treatment with PCI who follow up at University of California Davis Health.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICELiveCare

Patient use LiveCare device to monitor their blood pressure and data is transmitted to dashboard.

BEHAVIORALText Messages

Patients also receive text messages after their PCI procedure for follow up appointment reminders, enrollment in cardiac rehab, and diet and exercise counseling.

OTHERConventional Care

No digital monitoring with LiveCare device and no text messages.


Locations(1)

University of California, Davis Medical Center Division of Cardiovascular Medicine

Sacramento, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06114615


Related Trials